Home
|
News
|
Events
|
Contact Us
|
English
|
繁體中文
|
日本語
About Us
Product & Service
Facilities
Quality & Compliance
For Investors
Career
|
Company
|
Milestone
|
People
|
Mission Statement
|
Organization
|
Contact Us
|
|
Active Pharmaceutical Ingredients
|
Contract Development and Manufacturing Organization (CDMO)
|
Antibody Drug Conjugates (ADCs)
|
Injectable Manufacturing Services
|
|
Kilo Lab
|
Commercial Production
|
High Potency API (HPAPI)
|
Analytical instrument
|
|
DMFs & CEPs
|
Inspection
|
Certificates
|
SHE Policy
|
Intellectual Property
|
Award
|
|
Financials
|
Corporate Governance
|
Shareholder Services
|
Sustainable Development
|
FAQ
For Investors
Home
/
For Investors
/
Financials
/
Annual Reports
Annual Reports
2022
2022 Annual Report
2021
2021 Annual Report
2020
2020 Annual Report
2019
2019 Annual Report
2018
2018 Annual Report
2017
2017 Annual Report
2016
2016 Annual Report
2015
2015 Annual Report
2014
2014 Annual Report
2013
2013 Annual Report
2012
2012 Annual Report(final)
2012
2012 Annual Report
2011
2011 Annual Report (final)
2011
2011 Annual Report
2010
2010 Annual Report
2009
2009 Annual Report(final)
2009
2009 Annual Report
Financials
Annual Reports
Monthly Revenue
Finacial Reports
Corporate Governance
Board of Directors
Major Policies
Internal Audit
Major Resolutions
Shareholder Services
Stock Quotes & Dividend Data
Material Announcement
Shareholders' Meeting
Activities
Sustainable Development
Sustainable Development
Stakeholder Engagement
Public Welfare
FAQ
Common Share Transfer
Contacts
FAQ
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝